483
Sunshine Lake Pharma Co., LtdSunshine Lake Pharma Co., Ltd – FDA 483, Mar 22, 2024
Record Details
An FDA inspection of Sunshine Lake Pharma Co., Ltd. in Dongguan, China, revealed a significant failure in their quality management system. The firm's Quality Unit did not adhere to written procedures for annual product quality reviews, specifically neglecting to track and review 64 quality deviations over a period of several years. This indicates a lack of adequate oversight regarding product quality and deviation management.
View Company Profile
ID · 2eec2e95-4e99-47c8-90ae-48a090513990
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.